A phase 2 study of ipatasertib in combination with pembrolizumab for first line treatment of recurrent or metastatic squamous cell cancer of the head and neck

被引:0
|
作者
Thomas, Jacob S.
Hsu, Robert
Villaflor, Victoria
Riess, Jonathan
Nieva, Jorge
Krailo, Mark
Gutkind, Silvio
Colevas, Dimitri
机构
关键词
D O I
10.1158/1538-7445.AM2023-CT047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT047
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma
    Weiss, Jared M.
    Bagley, Stephen
    Hwang, Wei-Ting
    Bauml, Joshua
    Olson, Juneko Grilley
    Cohen, Roger B.
    Hayes, David Neil
    Langer, Corey
    CANCER, 2016, 122 (15) : 2350 - 2355
  • [22] Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Borcoman, Edith
    Marret, Gregoire
    Le Tourneau, Christophe
    CANCERS, 2021, 13 (11)
  • [23] A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma.
    Hu, Man
    Zhang, Shichuan
    Han, Yaqian
    Wu, Hui
    Gao, Jin
    Wu, Haijun
    Lin, Qin
    Shang, Wei
    Li, Xia
    Feng, Hong
    Qiao, Qiao
    Hu, Guangyuan
    Yang, Kunyu
    Song, Xicheng
    Cao, Yuandong
    Kang, Min
    Wang, Ruozheng
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate pepinemab in combination with pembrolizumab for first-line treatment of patients with recurrent or metastatic head and neck cancer
    Evans, Elizabeth E.
    Fisher, Terrence Lee
    Mallow, Crystal L.
    Foster, Amber
    Leonard, John E.
    Chaney, Marya F.
    Mekhail, Tarek
    Seetharamu, Nagashree
    Steuer, Conor Ernst
    Saba, Nabil F.
    Adkins, Douglas
    Beck, J. Thaddeus
    Algazi, Alain Patrick
    Burtness, Barbara
    Baumgart, Megan
    Giampoli, Ellen
    Hager, Steven Jeffrey
    Chay, Christopher H.
    Spira, Alexander I.
    Zauderer, Maurice
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Phase 2 study of dalantercept in recurrent or metastatic squamous cell carcinoma of the head and neck
    Jimeno, Antonio
    Posner, Marshall R.
    Weiss, Jared
    Wirth, Lori J.
    Saba, Nabil F.
    Cohen, Roger B.
    Popa, Elizabeta C.
    Argiris, Athanassios
    Grossmann, Kenneth F.
    Sukari, Ammar
    Korth, Chris
    Wilson, Dawn
    McClure, Ty
    Alimzhanov, Marat
    Pearsall, Scott
    Attie, Kenneth M.
    Sherman, Matthew L.
    Pandya, Shuchi Sumant
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan
    Wang, C. H.
    Lei, H. L.
    Borse, R.
    Chirovsky, D.
    Chien, L.
    Tan, S. C.
    Spiteri, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1349 - S1349
  • [27] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
  • [28] A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
    Rodriguez, Cristina P.
    Wu, Qian
    Voutsinas, Jenna
    Fromm, Jonathan R.
    Jiang, Xiuyun
    Pillarisetty, Venu G.
    Lee, Sylvia M.
    Santana-Davila, Rafael
    Goulart, Bernardo
    Baik, Christina S.
    Chow, Laura Q. M.
    Eaton, Keith
    Martins, Renato
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 837 - 845
  • [29] Phase II study of dasatinib in combination with cetuximab in recurrent/metastatic head and neck squamous cell carcinoma
    Stabile, Laura P.
    Egloff, Ann Marie
    Zhou, Pei
    Gooding, William E.
    Grandis, Jennifer R.
    Bauman, Julie E.
    CANCER RESEARCH, 2016, 76
  • [30] Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study
    Okada, Takuro
    Fushimi, Chihiro
    Matsuki, Takashi
    Tokashiki, Kunihiko
    Takahashi, Hideaki
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Hanyu, Kenji
    Kishida, Takuma
    Ito, Tatsuya
    Yamashita, Gai
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Koki
    Omura, Go
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2023, 43 (06) : 2717 - 2724